In a first, living mice are made transparent
When a dye called tartrazine is added to food, it creates a bright yellow hue…
Category: Life Sciences
.jpg)
Summit’s upcoming cancer results, Recursion’s mixed data, and the next big obesity target
How effective is Summit Therapeutics’ lung cancer immunotherapy? Why are obesity drugmakers turning back to…
Youth vaping continues its tumble from a Juul-fueled high
The number of U.S. kids who are using e-cigarettes has continued to tumble, new federal…
STAT+: The battle over race in kidney function equations
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning…
Medicare claims data offer clues on doctors most likely to offer telehealth visits
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology…
STAT+: U.K. charities give $36 million to start new drugs for childhood tumors
For three decades, adults have benefited from a revolution in oncology treatment, as immunotherapies and…
Nearly 2,000 drug manufacturing plants are overdue for FDA inspections after Covid delays
Federal regulators responsible for the safety of the U.S. drug supply are still struggling to…
.jpg)
Lilly has more positive data on its weekly insulin
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about China detaining AstraZeneca staff, pharma layoffs, and more
Rise and shine, another busy day is on the way. However, this is also shaping…
STAT+: Summit Therapeutics vs. Merck: Prepping for a big lung cancer study reveal
Let’s set the table for Sunday’s presentation of the lung cancer immunotherapy trial known as…
STAT+: Alnylam versus BridgeBio: The ATTR-CM debate
I coined the term “Typo-gate” to describe the misguided dustup Alnylam Pharmaceuticals executives instigated last…
STAT+: Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target
Nearly two decades ago, a small company called Amylin Pharmaceuticals saw that its first commercial…
Opinion: The truth behind that viral study on fluoride and IQ
A version of this essay first appeared in Jess Steier’s newsletter, “Unbiased Science.” Fluoride is…
Opinion: Eight former CDC directors: Hollowing out the CDC is a prescription for disaster
As former directors of the Centers for Disease Control and Prevention, we are deeply concerned…
Inside the bruising battle to purge race from a kidney disease calculator
There it was on James Cannon’s lab report, two tiny words: African American. The words…
Leading Breast Cancer Group Responds to Elle Macpherson’s Alternative Treatment Plan – Vanity Fair
Leading Breast Cancer Group Responds to Elle Macpherson’s Alternative Treatment Plan Vanity Fair Read Original Article:…
Beyond Meat to launch new steak alternative as it focuses on health – CNBC
Beyond Meat to launch new steak alternative as it focuses on health CNBC Read Original Article:…
STAT+: Humana cutting Medicare Advantage plans that cover 10% of members
Roughly 10% of people enrolled in Humana’s private Medicare plans will have to find new…
Depression: How brain scans helped predict long-term treatment outcomes
Depression has many faces. Some people can’t sleep, while others struggle to get out of…
Birth control vending machines, seasonal shots, and the “Snoo”
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning…
Moderna reports encouraging results on its mpox vaccine, as outbreaks in Africa spread
The emergence of a second mpox outbreak in which the virus is spreading from person…
Study of gender-affirming care reveals immune system sex differences
Researchers have long known that, in general, women are more susceptible to autoimmune disorders than…
STAT+: Pharmalittle: We’re reading about a Vaxcyte vaccine, Ozempic shortages, and more
Hello, everyone, and how are you today? We are doing just fine, thank you, especially…
BioMarin’s big day today
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Novartis to spend $200 million in further bid to boost radiopharma manufacturing, market dominance
Novartis is opening a new manufacturing facility in California and expanding an existing production site…
Trying to time your seasonal vaccines just right? There are no easy answers, but here are some factors to consider
With fall coming into view, public health officials across the country are turning to the…
Birth control has become harder to get. New York has some creative solutions
A typical vending machine on a university campus might offer students the usual range of…
Opinion: The Snoo can’t help the people who need it most
When you have a baby, sleep becomes the holy grail. You become convinced that getting…
How race became ubiquitous in medical decision-making tools
It was created with the best intentions: a government policy asking researchers to collect racial…
Elle Macpherson refused to have chemotherapy after breast cancer diagnosis – The Guardian
Elle Macpherson refused to have chemotherapy after breast cancer diagnosis The Guardian Read Original Article: Elle…
Elle McPherson: Supermodel reveals she had breast cancer – BBC.com
Elle McPherson: Supermodel reveals she had breast cancer BBC.com Read Original Article: Elle McPherson: Supermodel reveals…
STAT+: Drug aimed at strengthening neurons to treat Alzheimer’s fails in trial
A dark horse effort to treat Alzheimer’s disease, already marred by a data manipulation scandal,…
STAT+: Greece’s antitrust regulator probes Novartis over practices tied to a pricey eye drug
Greece’s antitrust regulator is investigating allegations that, over a nine-year period, Novartis paid doctors and…
STAT+: Vaxcyte shares boom as one of biotech’s big David vs. Goliath stories heats up
With new vaccine data released Tuesday, Vaxcyte, a San Carlos, Calif.-based firm, emerged as one…
STAT+: Dana-Farber CEO Laurie Glimcher to step down, saying ‘we must look to the next generation’
Laurie H. Glimcher, chief executive of Dana-Farber Cancer Institute, said she would step down next…
STAT+: Pharmalittle: We’re reading about Medicare drug prices, a Sanofi MS pill, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite —…
A STAT Investigation: Embedded Bias
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in…
STAT+: Recursion presents mixed data on lead AI-derived drug candidate for potentially fatal brain condition
Recursion Pharmaceuticals announced results of a clinical trial for its lead drug candidate Tuesday that,…
STAT+: European court sides with Illumina, saying regulators overstepped in scrutiny of Grail deal
LONDON — Europe’s top court on Tuesday ruled that regulators overstepped in challenging the DNA…
Explore the clinical tools that use race to steer care
Every day, physicians use clinical algorithms to make decisions about the patients in their exam…
Doctors use problematic race-based algorithms to guide care every day. Why are they so hard to change?
Pediatrician Alexandra Epee-Bounya had had enough. In her 20 years caring for children in Boston,…
STAT+: Diagnosed with cancer, a pharmaceutical executive became a patient advocate and changed drug development. It took decades
Kathy Giusti was diagnosed with multiple myeloma in 1996, when she was a 37-year-old executive…
Why clinicians are reconsidering race-based algorithms
Algorithms are ubiquitous in medicine. They can take the form of a flowchart, a simple…
Opinion: Letting funding for the All of Us research program lapse will cost the U.S. far more than it saves
I was in high school when I first encountered the ruthlessness of the number one…
STAT+: At major cardiology conference, Wegovy’s the word
LONDON — When Europe’s largest cardiology conference opened here this past Friday, one of the…
STAT+: Sanofi says its new pill for multiple sclerosis succeeded in a key trial, boosting its research ambitions
Sanofi said an oral treatment for multiple sclerosis, tolebrutinib, met its key goal in a…
STAT+: HCA and UnitedHealth resolve contract disputes in four states hours before deadline
HCA Healthcare and UnitedHealthcare reached agreements just hours before their contracts were scheduled to expire…
Opinion: The alliance between RFK Jr. and Trump all comes down to their health-related worldview
Robert F. Kennedy Jr.’s priorities may seem like a random grab bag of contrarianism, conspiracies,…
STAT+: A ‘tie-breaker’ study of Abbott’s heart clip brings more questions than answers
A study meant to serve as a tie-breaker between two major trials of a heart…
Oregon alternative medicine students face a long road to loan forgiveness – Oregon Public Broadcasting
Oregon alternative medicine students face a long road to loan forgiveness Oregon Public Broadcasting Read Original…